Cointime

SAGE Therapeutics

company

About

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

  • 501 - 1000

Highlights

Total Funding Amount
$58M
Funding Rounds
2
Investors
1
Investments
4
Lead Investments
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$20M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2010
Number Of Employee
501 - 1000
Operating Status
Active

SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$58M
SAGE Therapeutics has raised a total of $58M in funding over 2 rounds. Their latest funding was raised on Mar 13, 2014 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 13, 2014 Series C $38M 1 — — Detail
Oct 16, 2013 Series B $20M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
4
1
SAGE Therapeutics has made 4 investments. Their most recent investment was on Jun 6, 2021, when Snickerdoodle Labs raised $2.40M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 6, 2021 Snickerdoodle Labs
Seed $2.40M Blockchain —
Dec 17, 2019 Alchemy
Series A $15M Blockchain —
Sep 26, 2014 MoviePass
Series A $2.20M Apps Yes
Apr 1, 2014 Mavatar
Convertable Note $2M Affiliate Marketing —

Investors

Number of Lead Investors
Number of Investors
—
1
SAGE Therapeutics is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners — Series C
Cointime
Content
Company